Patients to be contacted if they are eligible for new treatment to manage obesity
Following the widely publicised announcement that patients with obesity can access the injectable weight-loss treatment Tirzepatide (also known as Mounjaro®) through primary care, work is underway within General Practice in Shropshire, Telford and Wrekin to identify those patients who are eligible to be considered for the treatment. According to calculations from the National Institute for…